Mitsubishi UFJ Trust & Banking
MYGN icon

Mitsubishi UFJ Trust & Banking’s Myriad Genetics MYGN Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-96,049
Closed -$1.09M – 1331
2020
Q2 		$1.09M Sell
96,049
-439,710
-82% -$6.24M ﹤0.01% 846
2020
Q1 		$7.67M Sell
535,759
-2,530
-0.5% -$53.4K 0.02% 554
2019
Q4 		$14.7M Buy
538,289
+21,690
+4% +$597K 0.04% 473
2019
Q3 		$14.8M Buy
516,599
+7,550
+1% +$220K 0.04% 451
2019
Q2 		$14.1M Buy
509,049
+7,460
+1% +$211K 0.05% 416
2019
Q1 		$16.7M Sell
501,589
-1,020
-0.2% -$31.1K 0.06% 350
2018
Q4 		$14.6M Buy
502,609
+1,110
+0.2% +$39.9K 0.06% 348
2018
Q3 		$23.1M Buy
501,499
+4,870
+1% +$217K 0.08% 291
2018
Q2 		$18.6M Sell
496,629
-17,370
-3% -$587K 0.03% 571
2018
Q1 		$15.2M Buy
513,999
+29,080
+6% +$984K 0.03% 611
2017
Q4 		$16.7M Buy
484,919
+23,360
+5% +$788K 0.03% 582
2017
Q3 		$16.7M Sell
461,559
-9,630
-2% -$275K 0.03% 567
2017
Q2 		$12.2M Sell
471,189
-4,570
-1% -$97K 0.02% 635
2017
Q1 		$9.13M Sell
475,759
-4,160
-0.9% -$73.7K 0.02% 655
2016
Q4 		$8M Sell
479,919
-4,970
-1% -$89.9K 0.02% 665
2016
Q3 		$9.98M Buy
484,889
+3,440
+0.7% +$87.2K 0.02% 638
2016
Q2 		$14.7M Sell
481,449
-8,200
-2% -$285K 0.03% 551
2016
Q1 		$18.3M Buy
489,649
+129,469
+36% +$4.88M 0.04% 486
2015
Q4 		$15.5M Sell
360,180
-9,310
-3% -$393K 0.04% 520
2015
Q3 		$13.8M Sell
369,490
-14,100
-4% -$500K 0.03% 532
2015
Q2 		$13M Sell
383,590
-15,710
-4% -$534K 0.03% 590
2015
Q1 		$14.1M Sell
399,300
-7,570
-2% -$271K 0.03% 561
2014
Q4 		$13.9M Sell
406,870
-33,900
-8% -$1.2M 0.03% 555
2014
Q3 		$17M Buy
440,770
+16,320
+4% +$609K 0.04% 466
2014
Q2 		$16.5M Buy
424,450
+18,900
+5% +$703K 0.04% 494
2014
Q1 		$13.9M Buy
405,550
+223,500
+123% +$6.92M 0.03% 526
2013
Q4 		$3.82M Sell
182,050
-3,050
-2% -$77.1K 0.01% 671
2013
Q3 		$4.35M Buy
+185,100
New +$5.26M 0.01% 661

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's MYGN Position: Q3 2020 in Review

Mitsubishi UFJ Trust & Banking sold out of Myriad Genetics (MYGN) in Q3 2020, closing a stake of 96,049 shares — an estimated $1.09M sold.

Mitsubishi UFJ Trust & Banking first reported a position in MYGN in Q3 2013 and held it in 28 quarters. The position peaked at $23.1M in Q3 2018. 192 funds tracked by Wall St. Rank hold MYGN as of Q3 2020.

  • Mitsubishi UFJ Trust & Banking reported no remaining Myriad Genetics position as of Q3 2020 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 96,049 Myriad Genetics shares in Q3 2020, an estimated $1.09M.
  • Mitsubishi UFJ Trust & Banking first reported a position in Myriad Genetics in Q3 2013 and held it in 28 quarters.
  • Mitsubishi UFJ Trust & Banking's Myriad Genetics position peaked at $23.1M in Q3 2018.
  • 192 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2020.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q3 2020, filed 12 Nov 2020.